Clinical Trials Logo

Filter by:
NCT ID: NCT00223977 Completed - Clinical trials for Iron Deficiency Anemia

2 Doses of Ferrlecit Versus Oral Iron to Treat Iron-deficiency Anemia in Peritoneal Dialysis Patients.

Start date: December 2003
Phase: Phase 2/Phase 3
Study type: Interventional

This is a phase 3 clinical investigation. Patients who meet the eligibility criteria and provide signed informed consent will be randomized to receive one of two levels of Ferrlecit or oral iron in a 1:1:1 ratio.

NCT ID: NCT00216619 Completed - Migraine Clinical Trials

The Prolonged Use of Topiramate for Preventing Migraine Headaches

PROMPT
Start date: November 2003
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the safety and effectiveness (beyond 6 months) of individualized doses (100 to 200 milligrams) of topiramate for the prevention of migraine headaches over a period of 26 weeks.

NCT ID: NCT00216476 Completed - Schizophrenia Clinical Trials

A Study of Relapse Prevention and the Effectiveness of Long-acting Injectable Risperidone and Quetiapine Tablets in the Treatment of Patients With Schizophrenia or Schizoaffective Disorder

Start date: October 2004
Phase: Phase 3
Study type: Interventional

The purpose of this study is to investigate whether a long-acting injectable formulation of risperidone provides better effectiveness over 2 years, as measured by the time to relapse, compared with quetiapine tablets in a routine psychiatric care setting. Aripiprazole will be investigated in a descriptive manner.

NCT ID: NCT00214578 Completed - Schizophrenia Clinical Trials

Seroquel on Glucose Metabolism

Start date: April 2004
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine whether six months treatment with the antipsychotic medicine Seroquel (quetiapine) may affect the schizophrenic patient's glucose metabolism

NCT ID: NCT00207740 Completed - Asthma Clinical Trials

A Study of Safety and Efficacy of CNTO 148 in Patients With Severe Persistent Asthma

Start date: August 2004
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the effectiveness and safety of CNTO 148 (golimumab) in patients with severe persistent asthma.

NCT ID: NCT00206310 Completed - Heart Failure Clinical Trials

Crestor Versus Placebo in Subjects With Heart Failure

Start date: September 2003
Phase: Phase 3
Study type: Interventional

The purpose of the study is to investigate if rosuvastatin, added on top of all other medicines prescribed to subjects with symptomatic systolic heart failure, reduces the combined endpoint of cardiovascular death or non-fatal myocardial infarction or non-fatal stroke (time to first event)

NCT ID: NCT00206167 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease

A Comparison of Symbicort® pMDI 2 x 160/4.5 μg Bid and 2 x 80/4.5 μg Bid With Formoterol Turbuhaler® 2 x 4.5 μg Bid and Placebo in Patients With COPD

Start date: April 2005
Phase: Phase 3
Study type: Interventional

The purpose of this study is to compare Symbicort in a pressurized metered-dose inhaler (pMDI) with formoterol and placebo in the long-term maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

NCT ID: NCT00206128 Completed - Schizophrenia Clinical Trials

Immediate Release (IR) to Sustained Release (SR) Switching Study: Study of Switching From IR Seroquel to SR Seroquel in Outpatients With Schizophrenia

Start date: November 2004
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine that the efficacy of the sustained release (SR) formulation of quetiapine (Seroquel) is not inferior to the immediate release (IR) formulation. PLEASE NOTE: Seroquel SR and Seroquel XR refer to the same formulation. The SR designation was changed to XR after consultation with FDA.

NCT ID: NCT00206115 Completed - Clinical trials for Schizophrenic Disorder

SR-Registration Study 1, ROW: Efficacy and Safety of Seroquel® in the Treatment of Patients With Schizophrenia

Start date: November 2004
Phase: Phase 3
Study type: Interventional

The purpose of this 6-week study is to determine whether treatment with Seroquel® Sustained Release (SR) is more effective than placebo in the treatment of acute schizophrenia. PLEASE NOTE: Seroquel SR and Seroquel XR refer to the same formulation. The SR designation was changed to XR after consultation with FDA.

NCT ID: NCT00205777 Completed - Osteoporosis Clinical Trials

Study Evaluating Bazedoxifene Acetate In Osteoporosis In Postmenopausal Women

Start date: December 2001
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine whether bazedoxifene acetate is safe and effective in the treatment of osteoporosis in postmenopausal women.